05.11.2015 • NewsDede WillamsR&Dcapacity expansion

Eli Lilly Expands R&D at Indianapolis

US drugmaker Eli Lilly plans to expand its research and development headquarters in Indianapolis, Indiana, to the tune of $70 million, adding floor space and a new disciplinary laboratory that will facilitate collaboration across multiple research functions.

The company said it expects to complete the expansion program by 2017. The new investment will further widen its footprint at its home base, where it spent $400 million two years ago to expand its insulin manufacturing capacity.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.